The work that Award supports is best represented by the term ‘translational glycobiology,’ as distinguished from ‘glycosciences’ and glycobiology,’ as the ultimate goal is to obtain translatable knowledge to boost the human being condition clinically, said Dr. Sackstein. Related StoriesNew UCLA study looks at primary care medical home in reducing childrens' repeat appointments to hospitalsLoyola Medication, Palos Community Medical center jointly release innovative telemedicine programCHOP's Buerger Center for Advanced Pediatric Care celebrates grand openingDr. Sackstein’s laboratory offers pioneered the creation of novel tools and reagents to plan discrete sugar modifications on the surface of live cells to accomplish predetermined biologic effects.Philip Shaul, Professor and Vice Chair for Research in Pediatrics and a member of the Harold C. Simmons Comprehensive Cancer Center. Today are significant Implications of the research that appears in Cell Reports. One million new situations of breast malignancy are diagnosed every year, and about two-thirds of these are hormone receptor-positive, signifying they contain receptors for the hormones estrogen and/or progesterone, based on the American Cancer Society. Estrogen receptor-positive breast malignancy is prevalent following menopause particularly. Resistance to commonly commonly used endocrine-based therapies occurs, which led the experts to recognize that important estrogen-independent procedures must be driving the cancers' development.